Enzymotec Ltd. Announces it has Been Granted Patents for INFAT(R)'s Uses in Canada and the US
February 03, 2014 09:06 ET
|
Enzymotec Ltd.
MIGDAL HA'EMEQ, Israel, Feb. 3, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, announced today that it was...
Enzymotec Ltd. Announces Completion of Its Migdal Ha'Emeq Manufacturing Facility Expansion
January 13, 2014 09:00 ET
|
Enzymotec Ltd.
MIGDAL HA'EMEQ, Israel, Jan. 13, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, today announced the...
Enzymotec Ltd. Announces "New Food Raw Material" Certification for K-REAL(R) Krill Oil in China
January 07, 2014 16:05 ET
|
Enzymotec Ltd.
MIGDAL HA'EMEQ, Israel, Jan. 7, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, announced today its...
Enzymotec Ltd. to Participate in the 16th Annual ICR XChange Conference
January 06, 2014 16:05 ET
|
Enzymotec Ltd.
MIGDAL HA'EMEQ, Israel, Jan. 6, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) ("Enzymotec"), a developer, manufacturer and marketer of innovative bio-functional lipid ingredients, announced...
Enzymotec Ltd. Granted Patent for a Lipid Preparation Use Method
January 06, 2014 08:00 ET
|
Enzymotec Ltd.
MIGDAL HA'EMEQ, Israel, Jan. 6, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-functional lipid ingredients, announced today that it...
Enzymotec Ltd. Announces Changes to Its Board of Directors
January 02, 2014 08:00 ET
|
Enzymotec Ltd.
MIGDAL HA'EMEQ, Israel, Jan. 2, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-functional lipid ingredients, announced today that it...
Enzymotec Ltd. Announces Signing of Settlement Term Sheet
December 18, 2013 08:01 ET
|
Enzymotec Ltd.
MIGDAL HA'EMEQ, Israel, Dec. 18, 2013 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) ("Enzymotec"), a developer, manufacturer and marketer of innovative bio-functional lipid ingredients, announced...
Enzymotec Ltd. Announces Publication Acceptance of Clinical Study Results on Usage of Vayacog(R) in Non-Demented Elderly
December 09, 2013 08:00 ET
|
Enzymotec Ltd.
MIGDAL HA'EMEQ, Israel, Dec. 9, 2013 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-functional lipid ingredients, announced today the...
Enzymotec Ltd. and Polar Omega A/S Sign a Joint Venture Agreement
December 04, 2013 08:00 ET
|
Enzymotec Ltd.
MIGDAL HA'EMEQ, Israel and ESBJERG, Denmark, Dec. 4, 2013 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-functional lipid ingredients, and...
Enzymotec Ltd. Announces Publication Acceptance of Clinical Study Results on K-REAL(TM) Usage Health Benefits
December 03, 2013 08:00 ET
|
Enzymotec Ltd.
MIGDAL HA'EMEQ, Israel, Dec. 3, 2013 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, announced today the acceptance...